Drug:
Reaction: HYPERSENSITIVITY
20260101 - 20261231
No. 801 - 900
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 801 | 26830790 |
CA |
56 | 2 |
Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Arthropathy, Condition aggravated, Contraindicated product administered, Delirium, Diabetes mellitus, Diarrhoea, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Drug intolerance, Drug tolerance decreased, Fatigue, Fibromyalgia, Gait disturbance, Glossodynia, Grip strength decreased, Hand deformity, Hypersensitivity, Liver injury, Mobility decreased, Muscular weakness, Nausea, Oedema, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Prescribed overdose, Prescribed underdose, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Seronegative arthritis, Swelling, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Underdose, Upper respiratory tract infection, Urticaria, Visual impairment, Vomiting, Weight decreased, Weight increased, Wheezing, Wound infection, Treatment failure, Drug ineffective, Off label use, Product use issue, Therapeutic product effect decreased, Maternal exposure during pregnancy, Product use in unapproved indication, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ALENDRONATE SODIUM, ETANERCEPT, DICLOFENAC, DICLOFENAC SODIUM, RITUXIMAB, LEFLUNOMIDE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, CELECOXIB, CELECOXIB, CELECOXIB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, TOCILIZUMAB, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, DESOXIMETASONE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, CALCIUM, SULFASALAZINE, |
||||
| 802 | 26830898 |
US |
2 | |
Hypersensitivity, Injection site pain, Injection site swelling, |
||||
DUPILUMAB, |
||||
| 803 | 26830929 |
US |
44 | 2 |
Paraesthesia oral, Oral pruritus, Paraesthesia oral, Tongue pruritus, Pyrexia, Hypersensitivity, Rash, Rash, Dyspnoea, Off label use, Product preparation issue, |
||||
BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, ALPRAZOLAM, |
||||
| 804 | 26830959 |
AU |
73 | 2 |
Cardiac arrest, Chest pain, Hypersensitivity, |
||||
CARBOPLATIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, GEMCITABINE HYDROCHLORIDE, |
||||
| 805 | 26831235 |
US |
17 | 1 |
Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 806 | 26831257 |
US |
83 | 2 |
Hypersensitivity, |
||||
INSULIN GLARGINE, |
||||
| 807 | 26831372 |
EU |
49 | 2 |
Malaise, Rash, Rash erythematous, Rash pruritic, Hypersensitivity, Injection site pruritus, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 808 | 26831411 |
US |
2 | |
Incorrect dose administered, Hypersensitivity, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 809 | 26831554 |
US |
21 | 2 |
Urticaria, Eye pain, Fatigue, Dyspnoea, Nausea, Myalgia, Headache, Skin exfoliation, Hypersensitivity, Arthralgia, |
||||
DUPILUMAB, |
||||
| 810 | 26831697 |
EU |
1 | |
Arrhythmia, Weight decreased, Hypotension, Hypoacusis, Movement disorder, Sleep disorder, Weight increased, Rash pruritic, Electrolyte imbalance, Blood uric acid increased, Dehydration, Confusional state, Hypersensitivity, Hypoacusis, Tinnitus, Nausea, Diarrhoea, Dry mouth, Decreased appetite, Muscle spasms, Chills, Gout, Dizziness, Malaise, Hypoaesthesia, Muscular weakness, Constipation, |
||||
ROSUVASTATIN CALCIUM, FUROSEMIDE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, SPIRONOLACTONE, FUROSEMIDE, |
||||
| 811 | 26831734 |
EU |
||
Tuberculosis, Colon cancer, Adverse drug reaction, Therapeutic product effect decreased, Bacterial infection, Hypersensitivity, Paradoxical psoriasis, |
||||
INFLIXIMAB, USTEKINUMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 812 | 26831778 |
US |
69 | 2 |
Asthma, Lower respiratory tract infection, Hypersensitivity, Multiple allergies, Bronchitis, Illness, |
||||
UPADACITINIB, |
||||
| 813 | 26832257 |
US |
1 | |
Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 814 | 26832284 |
US |
2 | |
Hypersensitivity, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 815 | 26832306 |
CO |
44 | 2 |
Asphyxia, Cough, Hypersensitivity, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 816 | 26832377 |
RU |
||
Crohn^s disease, Viral infection, Hypersensitivity, Bacterial infection, |
||||
GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, |
||||
| 817 | 26832602 |
IN |
60 | 1 |
Hypersensitivity, |
||||
CARBOPLATIN, |
||||
| 818 | 26832675 |
US |
68 | 2 |
Decreased activity, Fatigue, Dyspnoea, Productive cough, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 819 | 26832738 |
US |
||
Dysphagia, Flushing, Hypersensitivity, Pruritus, |
||||
DIMETHYL FUMARATE, DIMETHYL-FUMARATE, DIMETHYL FUMARATE KIT, |
||||
| 820 | 26832890 |
US |
44 | 2 |
Sinus disorder, Ear infection, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 821 | 26832933 |
US |
67 | 2 |
Urticaria, Pruritus, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 822 | 26832997 |
US |
||
Hypersensitivity, |
||||
SUZETRIGINE, |
||||
| 823 | 26833033 |
GB |
59 | 2 |
Kidney infection, Urinary tract infection, Headache, Hypersensitivity, Injection site bruising, Injection site pain, Flushing, Nasopharyngitis, Oropharyngeal pain, Urinary tract infection, Urinary tract infection, |
||||
OFATUMUMAB, OFATUMUMAB, |
||||
| 824 | 26833338 |
US |
2 | |
Urticaria, Hypersensitivity, Injection site erythema, |
||||
GUSELKUMAB, |
||||
| 825 | 26833511 |
US |
2 | |
Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 826 | 26833657 |
EU |
45 | 2 |
Hypersensitivity, Somnolence, Fear of death, |
||||
TIRZEPATIDE, INSULIN GLARGINE, INSULIN LISPRO-AABC, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 827 | 26833658 |
US |
2 | |
Hypersensitivity, |
||||
TIRZEPATIDE, |
||||
| 828 | 26833752 |
EU |
42 | 2 |
Hypersensitivity, |
||||
CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 829 | 26834263 |
CA |
43 | 2 |
Anti-cyclic citrullinated peptide antibody positive, Arthropathy, Rheumatoid factor positive, Blister, Wound, Condition aggravated, Arthralgia, Pericarditis, Pain, Fibromyalgia, Hypoaesthesia, Psoriatic arthropathy, Sleep disorder, Hand deformity, Muscular weakness, Breast cancer stage III, Infusion related reaction, Injury, Delirium, Sciatica, Pemphigus, Swollen joint count increased, Swelling, Synovitis, Joint swelling, Dislocation of vertebra, Amnesia, General physical health deterioration, Adverse event, Systemic lupus erythematosus, Blood cholesterol increased, Wound infection, Rheumatoid arthritis, Wheezing, Grip strength decreased, Sinusitis, Adverse drug reaction, Abdominal discomfort, Gait disturbance, Musculoskeletal stiffness, Adjustment disorder with depressed mood, Rheumatic fever, Discomfort, Mobility decreased, Glossodynia, Disability, Walking aid user, Joint range of motion decreased, Memory impairment, Drug intolerance, Weight decreased, Infection, Helicobacter infection, Malaise, Abdominal pain upper, Alopecia, Vomiting, Depression, Rash, Decreased appetite, Hepatic enzyme increased, Nausea, Liver injury, Oedema, Duodenal ulcer perforation, Diarrhoea, Fatigue, Hypertension, Headache, Drug hypersensitivity, Hypersensitivity, Type 2 diabetes mellitus, Drug ineffective, Therapeutic product effect decreased, Treatment failure, Live birth, Contraindicated product administered, Intentional product use issue, Off label use, Prescribed overdose, Product use in unapproved indication, Product use issue, Maternal exposure during pregnancy, Exposure during pregnancy, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, ALENDRONATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ABATACEPT, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, PREDNISONE, CERTOLIZUMAB PEGOL, ETANERCEPT, ETANERCEPT, ETANERCEPT, ALENDRONATE SODIUM, GOLIMUMAB, ADALIMUMAB, ABATACEPT, ABATACEPT, ABATACEPT, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB, TOFACITINIB CITRATE, TOFACITINIB, TOFACITINIB CITRATE, TOFACITINIB, TOFACITINIB CITRATE, TOFACITINIB, TOFACITINIB CITRATE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB CITRATE, TOFACITINIB CITRATE, APREMILAST, PREGABALIN, PREDNISONE, APREMILAST, CELECOXIB, USTEKINUMAB, SECUKINUMAB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CAFFEINE CITRATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LISINOPRIL, SULFASALAZINE, TOFACITINIB CITRATE, MELOXICAM, ERGOCALCIFEROL, QUETIAPINE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, PIROXICAM, CALCIUM, PANTOPRAZOLE, RAMIPRIL, RISEDRONATE SODIUM, MAGNESIUM, |
||||
| 830 | 26834442 |
US |
2 | |
Alopecia, Hypersensitivity, Skin burning sensation, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, EMPAGLIFLOZIN, ERGOCALCIFEROL, HYDROCHLOROTHIAZIDE, PREDNISONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, WARFARIN SODIUM, WARFARIN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, FUROSEMIDE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ALBUTEROL SULFATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, CALCIUM CARBONATE, OXYGEN, 0XYGEN, DULOXETINE HYDROCHLORIDE, DULOXETINE, LORATADINE, LORATADINE ORAL, LOSARTAN POTASSIUM, LOSARTAN, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, |
||||
| 831 | 26845715 |
30 | 1 | |
Death, Hypersensitivity, Contrast media reaction, |
||||
BELIMUMAB, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, CARVEDILOL, HYDROXYCHLOROQUINE, PREDNISONE, |
||||
| 832 | 26825008 |
US |
60 | 2 |
Hypersensitivity, |
||||
DUPILUMAB, AMLODIPINE BESYLATE, CALAMINE, ZINC OXIDE, FERRIC OXIDE RED, CALAMINE AND ZINC OXIDE, CALAMINE 8% AND ZINC OXIDE 8%, CALAMINE, PRAMOXINE HCL, CALAMINE 8%, ZINC OXIDE 8%, CALAMINE, PRAMOXIND HCL, CALAMINE, COLLAGENASE SANTYL, FAMOTIDINE, HYDROCHLOROTHIAZIDE, |
||||
| 833 | 26825028 |
US |
71 | 2 |
Hip arthroplasty, Urticaria, Pruritus, Hypersensitivity, |
||||
EVOLOCUMAB, EVOLOCUMAB, EZETIMIBE, |
||||
| 834 | 26825227 |
US |
2 | |
Hypersensitivity, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 835 | 26825371 |
US |
37 | 2 |
Hypersensitivity, Flushing, Panic attack, Chills, Tremor, White blood cell count increased, Product dose omission issue, |
||||
ASFOTASE ALFA, |
||||
| 836 | 26825417 |
US |
22 | 2 |
Hypersensitivity, Erythema of eyelid, Blepharitis, Erythema, Dermatitis, Hypoaesthesia oral, Eye irritation, |
||||
DUPILUMAB, |
||||
| 837 | 26825597 |
US |
||
Hypersensitivity, |
||||
MITOMYCIN, MITOMYCIN, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, |
||||
| 838 | 26825765 |
US |
56 | 2 |
Cough, Hypersensitivity, Product leakage, Product dose omission issue, Device issue, |
||||
| 839 | 26825855 |
US |
2 | |
Hypersensitivity, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 840 | 26825959 |
US |
2 | |
Hypersensitivity, |
||||
TIRZEPATIDE, |
||||
| 841 | 26825968 |
CA |
49 | 2 |
Pharyngitis streptococcal, Optic neuritis, Blindness, Optic ischaemic neuropathy, Hypersensitivity, Rash, Swollen tongue, Swelling face, Rash, Musculoskeletal chest pain, Oropharyngeal pain, Dyspnoea, Headache, Dermatitis allergic, Back pain, Oedema peripheral, Vasculitis, Oedema, Dizziness, Pharyngeal mass, Productive cough, Haemoptysis, Drug hypersensitivity, Sleep apnoea syndrome, Streptococcal infection, Pain, Emotional distress, Sexual dysfunction, Psoriasis, Induration, Skin exfoliation, Erythema, Pruritus, Injection site bruising, Drug ineffective, |
||||
AMOXICILLIN, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE, CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE, CALCIPOTRIENE, BETAMETHASONE DIPROPIONATE, USTEKINUMAB, |
||||
| 842 | 26826239 |
CA |
48 | 2 |
Nausea, Urticaria, Vomiting, Dyspnoea, Pruritus, Angioedema, Erythema, Dysarthria, Stridor, Obstructive airways disorder, Unresponsive to stimuli, Resuscitation, Anaphylactic reaction, Hypersensitivity, Rash, Oedema mucosal, Wheezing, |
||||
LORATADINE, LORATADINE TABLET, LORATADINE, LORATADINE TABLET, |
||||
| 843 | 26826364 |
US |
72 | 2 |
Myalgia, Pain, Eye pruritus, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 844 | 26826434 |
EU |
35 | |
Type I hypersensitivity, Pancytopenia, Peripheral swelling, Dyspnoea, Iron deficiency anaemia, Pruritus, Hypersensitivity, Off label use, |
||||
BULEVIRTIDE, BULEVIRTIDE, BULEVIRTIDE, TENOFOVIR DISOPROXIL FUMARATE, TENOFOVIR DISOPROXIL FUMARATE, |
||||
| 845 | 26826613 |
US |
59 | 1 |
Hypersensitivity, Rash, Dry skin, |
||||
DUPILUMAB, DUPILUMAB, TRALOKINUMAB-LDRM, |
||||
| 846 | 26826676 |
US |
2 | |
Illness, Weight increased, Blood potassium increased, Incontinence, Asthenia, Contusion, Alopecia, Nausea, Blood pressure increased, Hypersensitivity, Fatigue, Drug interaction, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LOSARTAN, |
||||
| 847 | 26827083 |
US |
80 | 2 |
Pain in extremity, Hypersensitivity, Tooth extraction, |
||||
AVAPRITINIB, AMLODIPINE, BIOTIN, MAGNESIUM HYDROXIDE, POLYETHYLENE GLYCOL 3350, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, HYDROCHLOROTHIAZIDE, LABETALOL, MONTELUKAST, MIRABEGRON, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ERGOCALCIFEROL, CETIRIZINE HYDROCHLORIDE, |
||||
| 848 | 26827236 |
CN |
47 | 2 |
Rash, Pruritus, Hypersensitivity, |
||||
DABRAFENIB, DABRAFENIB, TRAMETINIB, TRAMETINIB, |
||||
| 849 | 26827256 |
CA |
63 | |
Wheezing, Chest discomfort, Somnolence, Confusional state, Feeling abnormal, Asthenia, Dyspnoea, Hypersensitivity, Muscular weakness, Nausea, Productive cough, |
||||
ZOLEDRONIC ACID, |
||||
| 850 | 26827337 |
US |
5 | 2 |
Hypersensitivity, Rash pruritic, |
||||
DUPILUMAB, |
||||
| 851 | 26827755 |
US |
46 | 2 |
Hypersensitivity, Hypertension, |
||||
| 852 | 26827814 |
US |
61 | |
Hypersensitivity, |
||||
GLATIRAMER ACETATE, |
||||
| 853 | 26828084 |
US |
61 | 1 |
Hypersensitivity, |
||||
BIMEKIZUMAB, |
||||
| 854 | 26828421 |
US |
2 | |
Hypersensitivity, Blister, Product use in unapproved indication, Rash, |
||||
DUPILUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, AMLODIPINE, ARFORMOTEROL TARTRATE, BUDESONIDE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, PANTOPRAZOLE, ROSUVASTATIN CALCIUM, TRIAMTERENE CAPSULES, TRIAMTERENE, |
||||
| 855 | 26828715 |
US |
77 | 2 |
Skin cancer, Psoriasis, Nasal operation, COVID-19, Dermatitis, Hypersensitivity, Lip swelling, Eye irritation, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, |
||||
| 856 | 26828890 |
EU |
58 | 1 |
Seizure, Cough, Drug ineffective, Uveitis, Hepatic enzyme increased, BASDAI score increased, Granuloma, Splenomegaly, Hospitalisation, Speech disorder, Pyrexia, Back pain, Hypersensitivity, Tuberculosis, Pyrexia, Arthralgia, Mycobacterium tuberculosis complex test positive, C-reactive protein abnormal, C-reactive protein increased, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, INFLIXIMAB, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, |
||||
| 857 | 26829370 |
US |
||
Hypersensitivity, |
||||
CAFFEINE, |
||||
| 858 | 26829473 |
US |
2 | |
Alopecia, Hypersensitivity, |
||||
TIRZEPATIDE, |
||||
| 859 | 26832168 |
72 | 2 | |
Hypersensitivity, |
||||
FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, GABAPENTIN, CALCIUM, BIOTIN, |
||||
| 860 | 26833041 |
78 | 1 | |
Hypersensitivity, Therapy cessation, Photosensitivity reaction, Eye irritation, |
||||
LOTILANER OPHTHALMIC SOLUTION, |
||||
| 861 | 26833094 |
75 | 1 | |
Hypersensitivity, Anaphylactic shock, Chest discomfort, Nausea, Oxygen saturation decreased, |
||||
TIRZEPATIDE, TELMISARTAN, ROSUVASTATIN, |
||||
| 862 | 26844294 |
2 | ||
Intra-abdominal pressure increased, Hypersensitivity, Dermatitis, Hypoaesthesia, Dry skin, Skin exfoliation, Sensitive skin, |
||||
ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, |
||||
| 863 | 26819481 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bronchitis, Bursitis, C-reactive protein increased, C-reactive protein abnormal, Coeliac disease, Condition aggravated, Confusional state, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Liver function test increased, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal stiffness, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Normal newborn, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Upper respiratory tract infection, Urticaria, Wound, Inflammation, Wound infection, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ATOMOXETINE HYDROCHLORIDE, CANDESARTAN, APREMILAST, APREMILAST, APREMILAST, APREMILAST, AZATHIOPRINE, AZATHIOPRINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, GOLIMUMAB, GOLIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, MEPOLIZUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CALCIUM CARBONATE, ANTACID, |
||||
| 864 | 26819747 |
US |
78 | 1 |
Hypersensitivity, Rhinorrhoea, Oropharyngeal pain, |
||||
LENALIDOMIDE, DARATUMUMAB, |
||||
| 865 | 26819751 |
EU |
70 | 2 |
Hypersensitivity, Dyspnoea, Dysphonia, Diarrhoea, |
||||
OXALIPLATIN, CAPECITABINE, BEVACIZUMAB, |
||||
| 866 | 26819765 |
US |
82 | 2 |
Urinary tract infection, Contusion, Diarrhoea, Arterial occlusive disease, Product dose omission issue, Myalgia, Muscle spasms, Fatigue, Pain, Hypersensitivity, Urethral neoplasm, Hypotension, |
||||
VALSARTAN, VALSARTAN ORAL, EVOLOCUMAB, BACLOFEN, CETIRIZINE HYDROCHLORIDE, MONTELUKAST SODIUM, AMOXICILLIN, |
||||
| 867 | 26819786 |
US |
2 | |
Hypersensitivity, Erythema, Swelling face, Swollen tongue, Feeling hot, |
||||
BECLOMETHASONE DIPROPIONATE HFA, |
||||
| 868 | 26819810 |
US |
2 | |
Hypersensitivity, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 869 | 26819911 |
|||
Hepatic function abnormal, Condition aggravated, Drug reaction with eosinophilia and systemic symptoms, Pyrexia, Rash, Hypersensitivity, |
||||
OLANZAPINE, QUETIAPINE, QUETIAPINE, QUETIAPINE, VALPROATE SODIUM, HALOPERIDOL, HALOPERIDOL LACTATE, LITHIUM, LITHIUM BROMATUM, RISPERIDONE, AMOXICILLIN, |
||||
| 870 | 26820061 |
AU |
2 | |
Inflammation, Weight increased, Skin lesion, Hypersensitivity, |
||||
METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, |
||||
| 871 | 26820180 |
US |
46 | 2 |
Hypersensitivity, Pyrexia, Feeling cold, Feeling hot, Chills, Nausea, |
||||
OCRELIZUMAB, INTERFERON BETA-1A, AMLODIPINE, SERTRALINE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE (XL), TIZANIDINE, |
||||
| 872 | 26820427 |
CN |
||
Pneumonia, Renal failure, COVID-19, Flushing, Urticaria, Chills, Hypertension, Dyspnoea, Urinary tract infection, Upper respiratory tract infection, Hypersensitivity, Off label use, Off label use, Infection, Nephropathy, |
||||
RITUXIMAB, OBINUTUZUMAB, |
||||
| 873 | 26820559 |
US |
1 | |
Hypersensitivity, |
||||
NAPROXEN, NAPROXEN SODIUM, |
||||
| 874 | 26820683 |
US |
26 | 1 |
Rash pruritic, Scab, Hypersensitivity, Rhinorrhoea, Sneezing, Throat irritation, |
||||
DUPILUMAB, DUPILUMAB, HYDROXYZINE, PIMECROLIMUS, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 875 | 26820702 |
US |
58 | 2 |
Condition aggravated, Pruritus, Dry skin, Skin exfoliation, Sinusitis bacterial, Throat irritation, Eye pruritus, Acne, Fibromyalgia, Pain, Arthralgia, Muscle spasms, Alopecia, Conjunctivitis, Hypersensitivity, Knee arthroplasty, |
||||
DUPILUMAB, AMLODIPINE BESYLATE, BACLOFEN, CARVEDILOL, CELECOXIB, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, HALOBETASOL PROPIONATE, LORATADINE, LORATADINE ORAL, LOSARTAN POTASSIUM, LOSARTAN, ERGOCALCIFEROL, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 876 | 26820743 |
EU |
71 | 2 |
Anaphylactic shock, Hypersensitivity, Hypotension, Tachycardia, Loss of consciousness, Resuscitation, Paraesthesia, |
||||
OXALIPLATIN, OXALIPLATIN, GRANISETRON, GRANISETRON HYDROCHLORIDE, LEUCOVORIN CALCIUM, NIVOLUMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 877 | 26820785 |
US |
68 | 2 |
Compression fracture, Nausea, Decreased appetite, Vomiting, Hypersensitivity, Diarrhoea, Cough, Insomnia, Illness, |
||||
| 878 | 26820920 |
AU |
75 | 1 |
Urticaria, Hypertension, Drug hypersensitivity, Pruritus, Chest pain, Dyspnoea, Erythema, Rash erythematous, Rash papular, Rash macular, Pallor, Heart rate increased, Respiratory rate increased, Urticaria, Rash pruritic, Malaise, Tongue pruritus, Paraesthesia oral, Pruritus, Urticaria, Malaise, Rash, Hypersensitivity, |
||||
PREDNISONE, PREDNISONE, PYRIDOSTIGMINE BROMIDE ORAL, PYRIDOSTIGMINE BROMIDE ORAL, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, ROSUVASTATIN, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 879 | 26821012 |
US |
58 | 2 |
Hypersensitivity, Headache, Rash, |
||||
DUPILUMAB, |
||||
| 880 | 26821110 |
US |
76 | 2 |
Cough, Hypersensitivity, |
||||
ORAL SEMAGLUTIDE, |
||||
| 881 | 26821113 |
AR |
53 | 1 |
Thrombosis, Influenza, Acne, Therapy interrupted, Hypersensitivity, Malaise, |
||||
PANITUMUMAB, PANITUMUMAB, |
||||
| 882 | 26821376 |
US |
53 | 2 |
Pruritus, Eczema, Hypersensitivity, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 883 | 26821422 |
CA |
44 | |
Autoimmune disorder, Drug intolerance, Glossodynia, Helicobacter infection, Hypersensitivity, Ill-defined disorder, Infusion related reaction, Irritable bowel syndrome, Lower respiratory tract infection, Gastrointestinal disorder, Pain, Pericarditis, Peripheral swelling, Pregnancy, Pruritus, Pyrexia, Rheumatoid arthritis, Sinusitis, Stomatitis, Synovitis, Systemic lupus erythematosus, Therapeutic product effect decreased, Weight increased, Wound, Underdose, Treatment failure, Exposure during pregnancy, Maternal exposure during pregnancy, Maternal exposure timing unspecified, Prescribed overdose, Live birth, Contraindicated product administered, Product use issue, |
||||
MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LORAZEPAM, AZATHIOPRINE, CAFFEINE, CAFFEINE CITRATE, CELECOXIB, CELECOXIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, HYDROCORTISONE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERYTHROMYCIN, FLUOROMETHOLONE, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, INFLIXIMAB, SARILUMAB, LANSOPRAZOLE, LEFLUNOMIDE, LEFLUNOMIDE, LISINOPRIL, LISINOPRIL, LORAZEPAM, MELOXICAM, METHOTREXATE, METHOTREXATE SODIUM, MOXIFLOXACIN HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, HYDROXYCHLOROQUINE SULFATE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREGABALIN, LANSOPRAZOLE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, RITUXIMAB, ALBUTEROL SULFATE, ALBUTEROL, FLUOROMETHOLONE, LANSOPRAZOLE, LEFLUNOMIDE, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREGABALIN, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, RITUXIMAB-ABBS, USTEKINUMAB, VITAMIN C, TOFACITINIB, ACETAMINOPHEN AND CODEINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, ERGOCALCIFEROL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, SULFASALAZINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 884 | 26821562 |
PH |
12 | |
Hypersensitivity, Rash, Arrhythmia, |
||||
CEFUROXIME SODIUM, CEFUROXIME SODIUM, IPRATROPIUM BROMIDE, |
||||
| 885 | 26821620 |
2 | ||
Pulmonary congestion, Hypersensitivity, Product use in unapproved indication, |
||||
| 886 | 26821967 |
CA |
40 | 2 |
Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Wound, Synovitis, Stomatitis, Psoriatic arthropathy, Rheumatic fever, Vomiting, Rheumatoid arthritis, Wound infection, Taste disorder, Gastrooesophageal reflux disease, Swelling, Urticaria, Muscular weakness, Type 2 diabetes mellitus, Sleep disorder, Weight increased, Wheezing, Rash, Systemic lupus erythematosus, Gastrointestinal disorder, Abdominal discomfort, Back injury, Blepharospasm, Off label use, Product quality issue, Intentional product use issue, Product label confusion, Product use in unapproved indication, Therapeutic product effect decreased, Treatment failure, |
||||
ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ETANERCEPT, ETANERCEPT, ETANERCEPT, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, USTEKINUMAB, USTEKINUMAB, APREMILAST, APREMILAST, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, CANDESARTAN, CANDESARTAN, CANDESARTAN, OXYCODONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, AZATHIOPRINE, AZATHIOPRINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, RAMIPRIL, RAMIPRIL, RAMIPRIL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE, MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, MIRABEGRON, MIRABEGRON, MIRABEGRON, MIRABEGRON, MIRABEGRON, MIRABEGRON, MIRABEGRON, MIRABEGRON, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NICOTINAMIDE, NICOTINAMIDE, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, HYDROXYCHLOROQUINE SULFATE, RANITIDINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ERGOCALCIFEROL, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, THIAMINE HYDROCHLORIDE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB CITRATE, TOFACITINIB, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, TETRACYCLINE HYDROCHLORIDE, TETRACYCLINE HYDROCHLORIDE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CALCIUM, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, VITAMIN C, VITAMIN C, |
||||
| 887 | 26822076 |
US |
2 | |
Hypersensitivity, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 888 | 26822385 |
EU |
56 | 2 |
Drug reaction with eosinophilia and systemic symptoms, Hypersensitivity, Skin lesion, Cutaneous vasculitis, Loss of consciousness, Transaminases increased, Inflammatory marker increased, Thrombocytopenia, Hepatic steatosis, Cholelithiasis, Lymph node calcification, Eosinophil count increased, |
||||
RIBOCICLIB, BISOPROLOL FUMARATE, LEVOTHYROXINE SODIUM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, |
||||
| 889 | 26822425 |
US |
56 | 2 |
Hyperglycaemia, Oropharyngeal pain, Throat tightness, Dyspnoea, Fatigue, Paranasal sinus hypersecretion, Hypersensitivity, |
||||
PALBOCICLIB, INAVOLISIB, CALCIUM CARBONATE, ANTACID, FULVESTRANT, INSULIN LISPRO, INSULIN GLARGINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE, LINAGLIPTIN, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ERGOCALCIFEROL, ERGOCALCIFEROL, INSULIN LISPRO, CETIRIZINE HYDROCHLORIDE, CALCIUM, |
||||
| 890 | 26822605 |
AR |
45 | 2 |
Hypoglycaemia, Loss of consciousness, Syncope, Hypersensitivity, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 891 | 26823276 |
US |
45 | 2 |
Hypersensitivity, Lacrimation increased, Swelling, Syncope, |
||||
DUPILUMAB, |
||||
| 892 | 26823732 |
CA |
19 | 2 |
Rheumatoid arthritis, Pemphigus, C-reactive protein, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Confusional state, Dyspnoea, Ill-defined disorder, Arthralgia, Autoimmune disorder, Infusion related reaction, Blister, Condition aggravated, Contusion, Type 2 diabetes mellitus, Treatment failure, Deep vein thrombosis postoperative, Discomfort, Drug intolerance, Duodenal ulcer perforation, Fatigue, Folliculitis, Pericarditis, Gastrointestinal disorder, Rash, Rheumatic fever, Helicobacter infection, Wound, Hepatic enzyme increased, Hypersensitivity, Psoriatic arthropathy, Hypertension, Infection, Pain, Injury, Joint swelling, Lip dry, Liver disorder, Lower limb fracture, Lower respiratory tract infection, Lung disorder, Malaise, Mobility decreased, Musculoskeletal stiffness, Nasopharyngitis, Night sweats, Oedema, Osteoarthritis, Pruritus, Pyrexia, Sciatica, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swollen joint count increased, Systemic lupus erythematosus, Therapy non-responder, Urticaria, Weight increased, Liver injury, |
||||
TRAMADOL HYDROCHLORIDE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ALENDRONATE SODIUM, INFLIXIMAB, LORAZEPAM, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, ERGOCALCIFEROL, ALENDRONATE SODIUM, NEOMYCIN OINTMENT, OXYCODONE, POVIDONE-IODINE, RANITIDINE HYDROCHLORIDE, RITUXIMAB, SULFASALAZINE, GOLIMUMAB, USTEKINUMAB, LEFLUNOMIDE, ERGOCALCIFEROL, ERGOCALCIFEROL, THIAMINE HYDROCHLORIDE, VITAMIN C, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, DOXYCYCLINE, DOXYCYCLINE HYCLATE, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CAFFEINE, CANDESARTAN, CELECOXIB, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, DESOXIMETASONE, PIROXICAM, ETANERCEPT, FOLIC ACID, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB, HYDROXYCHLOROQUINE, ADALIMUMAB-ADAZ, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, LANSOPRAZOLE, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, QUETIAPINE FUMARATE, QUETIAPINE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, APREMILAST, PREDNISONE, PREDNISONE, PREGABALIN, ABATACEPT, RAMIPRIL, RISEDRONATE SODIUM, INFLIXIMAB, SULFASALAZINE, PREDNISONE, TOFACITINIB, TOFACITINIB, |
||||
| 893 | 26823962 |
US |
66 | 2 |
Oral discomfort, Rash, Constipation, Hypersensitivity, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 894 | 26823977 |
US |
63 | 2 |
Pruritus, Product dose omission issue, Hypersensitivity, Sneezing, Cough, Condition aggravated, Asthma, Skin abrasion, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 895 | 26824150 |
CN |
35 | 2 |
Hypersensitivity, Hypovolaemic shock, |
||||
GADOBENATE DIMEGLUMINE, |
||||
| 896 | 26824812 |
US |
2 | |
Diabetic ketoacidosis, Diabetic ketoacidosis, Hypersensitivity, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 897 | 26824884 |
US |
82 | 1 |
Hypersensitivity, Poliomyelitis, Iron deficiency, |
||||
DULAGLUTIDE, |
||||
| 898 | 26824969 |
EU |
58 | 1 |
Iridocyclitis, Hospitalisation, Tuberculosis, Pyrexia, Seizure, Speech disorder, Back pain, Arthralgia, General physical health deterioration, C-reactive protein increased, Pyrexia, Hypersensitivity, Cough, Mycobacterium tuberculosis complex test positive, C-reactive protein increased, Granuloma, Splenomegaly, Drug ineffective, |
||||
INFLIXIMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 899 | 26817786 |
BR |
22 | 2 |
Somnolence, Nausea, Hypersensitivity, Headache, Vomiting, |
||||
NATALIZUMAB, |
||||
| 900 | 26818008 |
US |
62 | 2 |
Neuropathy peripheral, Panic attack, Arthralgia, Body temperature fluctuation, Oral pain, Urinary tract infection, Hypersensitivity, Lip swelling, |
||||
DOSTARLIMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30